Aclaris Therapeutics Inc (ACRS) $22.28 (%)
-
Exchange
Nasdaq Global Select
About company
Aclaris Therapeutics, Inc., a biopharmaceutical company, focuses on developing drug candidates for immuno-inflammatory diseases in the United States. It operates in two segments, Therapeutics and Contract Research. The company offers ESKATA, a formulation of high-concentration hydrogen peroxide topical solution for raised seborrheic keratosis, a common non-malignant skin tumor. It is also developing A-101, a high-concentration formulation of hydrogen peroxide that is in Phase III clinical trial for common warts; and ATI-501 and ATI-502 Janus kinase (JAK) inhibitors, which are in Phase II clinical trials for alopecia areata (AA) and other dermatological indications. In addition, the company's products under development include ATI-450 an investigational oral, novel, small molecule selective MK2 inhibitor compound for the treatment of rheumatoid arthritis; ATI-1777 soft inhibitor for atopic dermatitis; and ATI-2138, an investigational oral ITK/TXK/JAK3, or ITJ, inhibitor compound, for the treatment of psoriasis inflammatory bowel disease. Further, it provides contract research services. Aclaris Therapeutics, Inc. has a license and collaboration agreement with Rigel Pharmaceuticals, Inc. for the development and commercialization of JAK inhibitors. The company was founded in 2012 and is headquartered in Wayne, Pennsylvania.
Income Statement
| Year |
Revenue |
Cost of revenues |
Gross profit |
Operating expensess |
Operating incomes |
Interest expense |
Income tax expenses |
Earnings before taxs |
Net income |
Earnings per share basics |
Earnings per share diluteds |
Dividend per shares |
Gross margins |
EBIT margins |
Profit margins |
EBITDA |
EBIT |
Earnings Before Tax Margins |
Net Profit Margins |
| 2020 |
274515.00 |
169559.00 |
104956.00 |
38668.00 |
66288.00 |
0.00 |
968.00 |
67091.00 |
57411.00 |
3.31 |
3.28 |
0.803333414346 |
0.382332477278109 |
0.300289471658 |
0.209136112780722 |
77344.00 |
66288.00 |
0.244398302460703 |
0.209136112780722 |
| 2019 |
260174.00 |
161782.00 |
98392.00 |
34462.00 |
6393.00 |
3576.00 |
10481.00 |
65737.00 |
55256.00 |
2.97145 |
2.97145 |
3.03705403822 |
0.378178 |
0.245720171885 |
0.212381 |
8186.00 |
6393.00 |
0.252666 |
0.212381 |
| 2018 |
265595.00 |
163756.00 |
101839.00 |
30941.00 |
70898.00 |
324.00 |
11872.00 |
72903.00 |
59531.00 |
2.97649 |
2.97649 |
2.74234021698 |
0.383437 |
0.266940266195 |
0.224142 |
85546.00 |
70898.00 |
0.274489 |
0.224142 |
| 2017 |
229234.00 |
141048.00 |
88186.00 |
26842.00 |
61344.00 |
2323.00 |
15738.00 |
64089.00 |
48351.00 |
2.3175 |
2.3025 |
2.43140686849 |
0.384698604918991 |
0.267604282087 |
0.210924208450753 |
76569.00 |
61344.00 |
0.27957894553164 |
0.210924208450753 |
| 2016 |
215639.00 |
131376.00 |
84263.00 |
24239.00 |
60024.00 |
1456.00 |
15685.00 |
61372.00 |
45687.00 |
2.07658 |
2.07658 |
2.20897805039 |
0.39076 |
0.278354101067 |
0.211868 |
73333.00 |
60024.00 |
0.284605 |
0.211868 |
| 2015 |
233715.00 |
140089.00 |
93626.00 |
22396.00 |
7123.00 |
733.00 |
19121.00 |
72515.00 |
53394.00 |
2.30422 |
2.30422 |
1.99566067658 |
0.400599 |
0.304772907173 |
0.228458 |
84505.00 |
7123.00 |
0.310271 |
0.228458 |
| 2014 |
182795.00 |
112258.00 |
70537.00 |
18034.00 |
52503.00 |
384.00 |
13973.00 |
53483.00 |
3951.00 |
1.61318 |
1.61318 |
1.817183144 |
0.38588 |
0.287223392325 |
0.216144 |
61813.00 |
52503.00 |
0.292585 |
0.216144 |
| 2013 |
17091.00 |
106606.00 |
64304.00 |
15305.00 |
48999.00 |
136.00 |
13118.00 |
50155.00 |
37037.00 |
1.41969 |
1.41969 |
11.338876116 |
0.376245 |
0.286694751624 |
0.216705 |
57048.00 |
48999.00 |
0.293459 |
0.216705 |
| 2012 |
156508.00 |
87846.00 |
68662.00 |
13421.00 |
55241.00 |
1088.00 |
1403.00 |
55763.00 |
41733.00 |
1.57673 |
1.57673 |
2.63181556135 |
0.438712 |
0.35295959312 |
0.266651 |
60128.00 |
55241.00 |
0.356295 |
0.266651 |
| 2011 |
108249.00 |
64431.00 |
43818.00 |
10028.00 |
3379.00 |
519.00 |
8283.00 |
34205.00 |
25922.00 |
0.98833 |
0.98833 |
0.0 |
0.404789 |
0.312150689614 |
0.239466 |
36538.00 |
3379.00 |
0.315984 |
0.239466 |
| 2010 |
65225.00 |
39541.00 |
25684.00 |
7299.00 |
18385.00 |
311.00 |
4527.00 |
1854.00 |
14013.00 |
0.54121 |
0.54121 |
0.0 |
0.393775 |
0.281870448448 |
0.214841 |
19878.00 |
18385.00 |
0.284247 |
0.214841 |
| 2009 |
42905.00 |
25683.00 |
17222.00 |
5482.00 |
1174.00 |
407.00 |
3831.00 |
12066.00 |
8235.00 |
0.32426 |
0.32426 |
0.0 |
0.401398 |
0.2812 |
0.191936 |
13207.00 |
12066.00 |
0.281226 |
0.191936 |
| Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|
| Revenue | 274515.00 | 260174.00 | 265595.00 | 229234.00 | 215639.00 | 233715.00 | 182795.00 | 17091.00 | 156508.00 | 108249.00 | 65225.00 | 42905.00 |
|---|
| Cost of revenues | 169559.00 | 161782.00 | 163756.00 | 141048.00 | 131376.00 | 140089.00 | 112258.00 | 106606.00 | 87846.00 | 64431.00 | 39541.00 | 25683.00 |
|---|
| Gross profit |
104956.00 |
98392.00 |
101839.00 |
88186.00 |
84263.00 |
93626.00 |
70537.00 |
64304.00 |
68662.00 |
43818.00 |
25684.00 |
17222.00 |
|---|
| Operating expensess | 38668.00 | 34462.00 | 30941.00 | 26842.00 | 24239.00 | 22396.00 | 18034.00 | 15305.00 | 13421.00 | 10028.00 | 7299.00 | 5482.00 |
|---|
| Operating incomes | 66288.00 | 6393.00 | 70898.00 | 61344.00 | 60024.00 | 7123.00 | 52503.00 | 48999.00 | 55241.00 | 3379.00 | 18385.00 | 1174.00 |
|---|
| Interest expense | 0.00 | 3576.00 | 324.00 | 2323.00 | 1456.00 | 733.00 | 384.00 | 136.00 | 1088.00 | 519.00 | 311.00 | 407.00 |
|---|
| Income tax expenses | 968.00 | 10481.00 | 11872.00 | 15738.00 | 15685.00 | 19121.00 | 13973.00 | 13118.00 | 1403.00 | 8283.00 | 4527.00 | 3831.00 |
|---|
| Earnings before taxs | 67091.00 | 65737.00 | 72903.00 | 64089.00 | 61372.00 | 72515.00 | 53483.00 | 50155.00 | 55763.00 | 34205.00 | 1854.00 | 12066.00 |
|---|
| Net income | 57411.00 | 55256.00 | 59531.00 | 48351.00 | 45687.00 | 53394.00 | 3951.00 | 37037.00 | 41733.00 | 25922.00 | 14013.00 | 8235.00 |
|---|
| Earnings per share basics | 3.31 | 2.97145 | 2.97649 | 2.3175 | 2.07658 | 2.30422 | 1.61318 | 1.41969 | 1.57673 | 0.98833 | 0.54121 | 0.32426 |
|---|
| Earnings per share diluteds | 3.28 | 2.97145 | 2.97649 | 2.3025 | 2.07658 | 2.30422 | 1.61318 | 1.41969 | 1.57673 | 0.98833 | 0.54121 | 0.32426 |
|---|
| Dividend per shares | 0.8 | 3.04 | 2.74 | 2.43 | 2.21 | 2 | 1.82 | 11.34 | 2.63 | 0 | 0 | 0 |
|---|
| Gross margins | 0.38 | 0.38 | 0.38 | 0.38 | 0.39 | 0.4 | 0.39 | 0.38 | 0.44 | 0.4 | 0.39 | 0.4 |
|---|
| EBIT margins | 0.3 | 0.25 | 0.27 | 0.27 | 0.28 | 0.3 | 0.29 | 0.29 | 0.35 | 0.31 | 0.28 | 0.28 |
|---|
| Profit margins | 0.21 | 0.21 | 0.22 | 0.21 | 0.21 | 0.23 | 0.22 | 0.22 | 0.27 | 0.24 | 0.21 | 0.19 |
|---|
| EBITDA | 77344.00 | 8186.00 | 85546.00 | 76569.00 | 73333.00 | 84505.00 | 61813.00 | 57048.00 | 60128.00 | 36538.00 | 19878.00 | 13207.00 |
|---|
| EBIT | 66288.00 | 6393.00 | 70898.00 | 61344.00 | 60024.00 | 7123.00 | 52503.00 | 48999.00 | 55241.00 | 3379.00 | 18385.00 | 12066.00 |
|---|
| Earnings Before Tax Margins | 0.24 | 0.25 | 0.27 | 0.28 | 0.28 | 0.31 | 0.29 | 0.29 | 0.36 | 0.32 | 0.28 | 0.28 |
|---|
| Net Profit Margins | 0.21 | 0.21 | 0.22 | 0.21 | 0.21 | 0.23 | 0.22 | 0.22 | 0.27 | 0.24 | 0.21 | 0.19 |
|---|
